Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Teva
Fuji
McKesson
Fish and Richardson
Boehringer Ingelheim
Argus Health
AstraZeneca
Federal Trade Commission

Generated: January 23, 2018

DrugPatentWatch Database Preview

Selegiline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for selegiline hydrochloride and what is the scope of selegiline hydrochloride freedom to operate?

Selegiline hydrochloride
is the generic ingredient in three branded drugs marketed by Somerset, Apotex, Dava Pharms Inc, Lannett Holdings Inc, Valeant Pharm Intl, Apotex Inc, Boscogen, Chartwell Molecules, G And W Labs Inc, Mylan, and Siegfried, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for selegiline hydrochloride. Nine suppliers are listed for this compound.

US Patents and Regulatory Information for selegiline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Holdings Inc SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075145-001 Sep 15, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075321-001 Dec 4, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074871-001 Jun 6, 1997 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boscogen SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074912-001 Apr 30, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Siegfried SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074672-001 Apr 1, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharm Intl ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Somerset SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 019334-001 Jun 5, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Molecules SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074641-001 Aug 2, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Molecules SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074565-001 Aug 2, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Somerset ELDEPRYL selegiline hydrochloride CAPSULE;ORAL 020647-001 May 15, 1996 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for selegiline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 ➤ Subscribe ➤ Subscribe
Valeant Pharm Intl ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Medtronic
McKesson
Accenture
Moodys
UBS
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot